AU3263301A - Method for treating allergic diseases - Google Patents

Method for treating allergic diseases

Info

Publication number
AU3263301A
AU3263301A AU32633/01A AU3263301A AU3263301A AU 3263301 A AU3263301 A AU 3263301A AU 32633/01 A AU32633/01 A AU 32633/01A AU 3263301 A AU3263301 A AU 3263301A AU 3263301 A AU3263301 A AU 3263301A
Authority
AU
Australia
Prior art keywords
allergic diseases
treating allergic
treating
diseases
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32633/01A
Inventor
Pope Mosley
Erik Wallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Publication of AU3263301A publication Critical patent/AU3263301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU32633/01A 1999-12-07 2000-11-29 Method for treating allergic diseases Abandoned AU3263301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45459699A 1999-12-07 1999-12-07
US09454596 1999-12-07
PCT/US2000/032461 WO2001041703A2 (en) 1999-12-07 2000-11-29 Method for treating allergic diseases

Publications (1)

Publication Number Publication Date
AU3263301A true AU3263301A (en) 2001-06-18

Family

ID=23805279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32633/01A Abandoned AU3263301A (en) 1999-12-07 2000-11-29 Method for treating allergic diseases

Country Status (2)

Country Link
AU (1) AU3263301A (en)
WO (1) WO2001041703A2 (en)

Also Published As

Publication number Publication date
WO2001041703A2 (en) 2001-06-14
WO2001041703A3 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU1294401A (en) Methods for treating fibroproliferative diseases
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU2001257903A1 (en) Method for treatment of neurodegenerative diseases
AU2001286983A1 (en) Method of treatment
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2001240046A1 (en) Method of treating skin conditions
AU5733099A (en) Method for treating ocular neovascular diseases
AU4552200A (en) Method of treating psychotic disorders
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2055199A (en) Artificial fur and method for its manufacture
AU6252699A (en) Composition and method for treating allergic diseases
AUPP870999A0 (en) Method of treatment of equine disease
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2001262177A1 (en) Method of treatment
AU2924400A (en) Plant treatment method
AU4598400A (en) Method of treatment
AU6234000A (en) Methods for treating autoimmune diseases
AU3263301A (en) Method for treating allergic diseases
AU4914600A (en) Method for treating tnf-receptor type-2-induced diseases
AU2382601A (en) Novel method of treatment
AU6391199A (en) Composition and method for treating allergic diseases
AU1108101A (en) Method of treating plants
AU1784701A (en) Method of treating neuroblastoma
AU9198898A (en) Methods for treating ocular diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase